glp-1/gip receptor agonist GLP-1 Agonists Explained for Pharmacy & Medical Students: Mechanism, Uses, and Side Effects The Clinical Application of GLP-1RAs

For these cases, Al-Aly wondered if what he was hearing from his patients about how they were able to quit drinking or smoking after starting GLP-1 medication might apply more broadly to any substance

The bottom line Ozempic and Wegovy are semaglutide

Obesity (Silver Spring) 28(6):10501061

Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A

While tirzepatide has yet to demonstrate direct cardiovascular risk outcomes in patients without type 2 diabetes, tirzepatide-treated groups did demonstrate reductions in cardiometabolic variables resulting in a significantly lower 10-year predicted ASCVD risk in patients with overweight or obesity without type 2 diabetes in post hoc analysis of the SURMOUNT-1 trial [49]